Pseudoprotodioscin
CAS: 102115-79-7
Ref. 3D-OP31761
1g | 741,00 € | ||
2g | 2.314,00 € | ||
100mg | 209,00 € | ||
250mg | 363,00 € | ||
500mg | 478,00 € |
Información del producto
- (3β,25R)-26-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→4)]-β-<smallcap>D</span>-glucopyranoside
- Oligofurostanoside A
- Protodioscin, Pseudo-
- Pseudo-Protodioscin
- Pseudoprototribestin
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,25R)-26-(β-<smallcap>D</smallcap>-glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</span>-mannopyranosyl-(1→4)]-
Pseudoprotodioscin is a soybean extract that has been shown to have anti-inflammatory, anti-atherosclerotic, and anti-autoimmune effects. It is a natural product that belongs to the group of protodioscin derivatives. The cytotoxic effects of pseudoprotodioscin have been studied in 3T3-L1 preadipocytes. This molecule is also an inhibitor of DNA polymerase, which may account for its significant cytotoxic activity against tumor cells. Pseudoprotodioscin has been shown to be effective in the treatment of bowel diseases such as ulcerative colitis and Crohn's disease, as well as prostate cancer. Molecular docking analysis suggests that pseudoprotodioscin binds to the surface of DNA gyrase and prevents it from binding with the complementary strand of DNA during replication. This inhibition leads to cell death by preventing DNA synthesis and cell division.
Propiedades químicas
Consulta técnica sobre: 3D-OP31761 Pseudoprotodioscin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.